Skip to content
Trial Eligibility
Menu

Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

NCT03374215

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: The adrenal gland makes the hormone aldosterone. This helps regulate blood pressure. An adrenal gland tumor that makes too much aldosterone can cause high blood pressure and low potassium. The cause of these tumors is unknown, but sometimes they are inherited. Objective: To study the genes that may cause primary aldosteronism in Black individuals.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Adrenal Gland Neoplasm
  • Hypertension
  • Bone Diseases, Metabolic
  • Cardiovascular Disease
  • Hyperinsulinemia

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
7 to 70 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last updated on ClinicalTrials.gov
October 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.